Biomarkers such as NT-proBNP and CPP are widely recognized indicators of HF severity and therapeutic response.[31,32] NT-proBNP is a peptide hormone released in response to increased cardiac wall stress and is strongly associated with HF severity. This evidence concerns the gene NPPB and hydrops fetalis.